深耕创新沃土，布局未来医疗——专访直观医疗全球董事会主席古迦睿

Core Insights - Intuitive Surgical, a leader in surgical robotics, emphasizes its commitment to Shanghai and the digital transformation of healthcare, aiming to provide minimally invasive and precise medical solutions globally [1][2]. Group 1: Company Strategy and Market Position - Intuitive Surgical is the largest surgical robotics company globally, with over 16.94 million surgeries performed, including more than 2.68 million in 2024 alone [2]. - The company believes that China offers not only a vast market but also a significant source of innovation in medical technology, highlighting the importance of a robust healthcare ecosystem [2][5]. - The establishment of a local joint venture with Fosun Pharma in 2017 marked a significant step in Intuitive Surgical's localization strategy in China [4]. Group 2: Ecosystem Development and Policy Support - The Shanghai government has introduced initiatives to enhance the high-end medical device industry, aligning with Intuitive Surgical's technological focus [2][3]. - Recommendations for improving the medical technology ecosystem in Shanghai include promoting digital surgical technologies and creating an international center for surgical robotics [3]. Group 3: Technological Advancements and AI Integration - Intuitive Surgical is investing in AI and machine learning to enhance surgical outcomes, with the latest Da Vinci system boasting 10,000 times the computational power of previous models [7][8]. - The company advocates for a collaborative approach in surgery, emphasizing the synergy between surgeons, medical teams, and AI rather than automation replacing human roles [8][9]. Group 4: Future Outlook and Industry Trends - The future of the medical technology industry is expected to see significant breakthroughs driven by high-precision tools, AI, and integrated data solutions [7]. - Intuitive Surgical envisions competition in the industry will shift towards comprehensive ecosystem capabilities rather than just product comparisons [9].